BCL2 and lymphoma: A previous report described studies indicating that germline insertion of the E571K XPO1 mutation could accelerate development of lymphoma in mice made to express high-level c-Myc and BCL-2, suggesting such XPO1 mutations could contribute to oncogenic transformation [24].